Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Uracil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.68 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | TYMP | P19971 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uracil SCHEMBL27495406 | 1.00 | CRBN (0.68) | CRBNMMP2TP53CA1CYP1A2 | |
| Uracil SCHEMBL27509565 | 1.00 | CRBN (0.68) | CRBNMMP2TP53CA1CYP1A2 | |
| Uracil SCHEMBL479740 | 0.88 | CRBN (0.74) | CRBNMMP2TP53CA1CYP1A2 | |
| Uracil SCHEMBL2895220 | 0.86 | CRBN (0.71) | CRBNMMP2TP53CA1CYP1A2 | |
| Uracil SCHEMBL3798527 | 0.82 | CRBN (1.00) | CRBNMMP2TP53CA1ALDH1A1 | |
| Uracil SCHEMBL8235 | 0.82 | — | — | |
| Uracil SCHEMBL5089507 | 0.82 | — | — | |
| Uracil SCHEMBL9429688 | 0.81 | CRBN (0.77) | CRBNMMP2TP53CYP1A2ALDH1A1 | |
| Uracil SCHEMBL25208560 | 0.81 | CRBN (0.63) | CRBNMMP2TP53CYP1A2ALDH1A1 | |
| Uracil SCHEMBL4664232 | 0.80 | CRBN (0.94) | CRBNMMP2TP53CA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060245-A | Antistatic resin composition | 东邦化学工业株式会社 | 2026-05-19 | — | — | CN | disclosed |
| EP-4722292-A1 | YELLOW-AZO-PIGMENT-CONTAINING COLORING COMPOSITION AND METHOD FOR PRODUCING SAME | Otsuka Chemical Co., Ltd. (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12577421-B2 | Inkjet ink, ink set, ink medium set, and printing medium | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12552952-B2 | Inkjet ink, inkjet recording method, ink set, ink medium set, and print medium | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-02-17 | — | — | US | disclosed |
| EP-4692255-A1 | AQUEOUS INK COMPOSITION, INK SET, AND METHOD FOR PRODUCING INKJET-PRINTED MATTER | Nippon Kayaku Kabushiki Kaisha (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4570873-A1 | INKJET INK, INK SET, INK MEDIUM SET, AND PRINTING MEDIUM | Nippon Kayaku Kabushiki Kaisha (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-116997616-B | Ink set, ink jet recording method, ink medium set, and printing medium | 日本化药株式会社 | 2025-06-10 | — | — | CN | disclosed |
| US-20250179318-A1 | INKJET INK | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2025-06-05 | — | — | US | disclosed |
| CN-116137841-B | Coloring dispersion for inkjet, ink for inkjet recording, and inkjet recording method | 日本化药株式会社 | 2025-04-25 | — | — | CN | disclosed |
| EP-4502086-A1 | INKJET INK | Nippon Kayaku Kabushiki Kaisha (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-3950859-A1 | COLORED DISPERSION, RECORDING MEDIUM, AND HYDROPHOBIC FIBER PRINTING METHOD | Nippon Kayaku Kabushiki Kaisha (JP) | 2022-02-09 | — | — | EP | disclosed |
| WO-2022025166-A1 | COLORED DISPERSION FOR INKJET, INKJET RECORDING INK, AND INKJET RECORDING METHOD | 日本化薬株式会社 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022025034-A1 | COLORED FLUID, INK SET, RECORDING MEDIUM, AND TEXTILE PRINTING METHOD FOR HYDROPHOBIC FIBERS | 日本化薬株式会社 | 2022-02-03 | — | — | WO | disclosed |
| EP-2235122-B1 | MAGENTA RECORDING INK COMPOSITION, INKJET RECORDING METHOD, AND INK RECORDED MATTER | RICOH CO LTD (JP) | 2015-08-26 | — | — | EP | disclosed |
| CN-101925661-B | Magenta recording ink composition, ink jet recording method and ink recorded matter | RICOH KK | 2013-09-25 | — | — | CN | disclosed |
| US-8523992-B2 | Magenta recording ink composition, inkjet recording method, and ink recorded matter | RICOH COMPANY, LTD. (JP) | 2013-09-03 | — | — | US | disclosed |
| CN-101925661-A | Magenta recording ink composition, ink jet recording method and ink recorded matter | RICOH KK | 2010-12-22 | — | — | CN | disclosed |
| US-20100285287-A1 | MAGENTA RECORDING INK COMPOSITION, INKJET RECORDING METHOD, AND INK RECORDED MATTER | RICOH COMPANY, LTD. (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-2235122-A1 | MAGENTA RECORDING INK COMPOSITION, INKJET RECORDING METHOD, AND INK RECORDED MATTER | Ricoh Company, Ltd. (JP) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009093721-A1 | MAGENTA RECORDING INK COMPOSITION, INKJET RECORDING METHOD, AND INK RECORDED MATTER | RICOH COMPANY, LTD. (JP) | 2009-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552952-B2 | Inkjet ink, inkjet recording method, ink set, ink medium set, and print medium | BMP1, SMAD2, SMAD3 | CRBN 916/4885MMP2 1628/4885TP53 105/4885 |
| US-12577421-B2 | Inkjet ink, ink set, ink medium set, and printing medium | MITF, EYA3, EYA2 | CRBN 1048/4885MMP2 2219/4885TP53 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.